| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | -0.051 | 0.8 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.0099 | 0.8 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |